Natalie Sacks, Chief Medical Officer at ADURO BIOTECH, INC. (ADRO), sold 9,770 shares at $11.71 ($114K) on 2017-09-01, disclosed to the SEC on 2017-09-06.
Open-market sale of $114k ADRO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.71 | 4,885 | $57K | 50.0% |
| 2 | $11.71 | 4,885 | $57K | 50.0% |
| Total | $11.71 avg | 9,770 | $114K | 100% |
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |